Results 101 to 110 of about 38,166 (233)

Effect of maternal immunisation with multivalent vaccines containing inactivated poliovirus vaccine (IPV) on infant IPV immune response: A phase 4, multi-centre randomised trial.

open access: yesVaccine, 2023
N. Grassly   +10 more
semanticscholar   +1 more source

Intradermal Administration of Fractional Doses of Inactivated Poliovirus Vaccine: A Dose-Sparing Option for Polio Immunization

open access: yesJournal of Infectious Diseases, 2017
A fractional dose of inactivated poliovirus vaccine (fIPV) administered by the intradermal route delivers one fifth of the full vaccine dose administered by the intramuscular route and offers a potential dose-sparing strategy to stretch the limited ...
H. Okayasu   +7 more
semanticscholar   +1 more source

Immunogenicity and Reactogenicity of Diphtheria—Tetanus—Acellular Pertussis—Hepatitis B—Inactivated Poliovirus and Haemophilus influenzae Type B Vaccines Administered Concomitantly to Infants as a Three-dose Primary Course

open access: yesJournal of the Formosan Medical Association, 2011
Immunogenicity and reactogenicity of primary vaccination with combined diphtheria–tetanus–acellular pertussis–hepatitis B–inactivated poliovirus (DTPa–HBV–IPV) vaccine when co-administered with Haemophilus influenzae (Hib) conjugate vaccine were assessed
Pei-Lan Shao   +4 more
doaj   +1 more source

Immunogenicity and safety of the diphtheria, pertussis, tetanus and inactivated poliovirus vaccine when co-administered with the human rotavirus vaccine (Rotarix) in healthy Japanese infants: a phase IV randomized study

open access: yesHuman Vaccines & Immunotherapeutics, 2019
Rotavirus infections have been reported to account for 40–50% of all hospitalized acute gastroenteritis cases in young children (
P. Gillard   +8 more
semanticscholar   +1 more source

Advances and challenges in poliomyelitis vaccines: a comprehensive review of development, production, and global deployment

open access: yesFrontiers in Public Health
Poliomyelitis has been a significant global health challenge for centuries. Since the launch of the Global Polio Eradication Initiative (GPEI) in 1988, remarkable progress has been achieved, with wild poliovirus (WPV) cases reduced by over 99%.
Jia Liang, Qi Zhang, Yanan Li, Lili Wang
doaj   +1 more source

Decay of Sabin inactivated poliovirus vaccine (IPV)-boosted poliovirus antibodies

open access: yesTrials in Vaccinology, 2015
We conducted a follow-on study to a phase I randomized, controlled trial conducted in Cuba, 2012, to assess the persistence of poliovirus antibodies at 21-22 months following booster dose of Sabin-IPV compared to Salk-IPV in adults who had received multiple doses of oral poliovirus vaccine (OPV) during childhood.In 2012, 60 healthy adult males aged 19 ...
Sonia Resik   +8 more
openaire   +2 more sources

Immunogenicity and Reactogenicity of DTPa-IPV/Hib Vaccine Co-administered With Hepatitis B Vaccine for Primary and Booster Vaccination of Taiwanese Infants

open access: yesJournal of the Formosan Medical Association, 2011
Immunogenicity and reactogenicity of the combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b (Hib) conjugate vaccine (DTPa-IPV/Hib, Infanrix™-IPV + Hib) was assessed when co-administered with hepatitis B ...
Pei-Lan Shao   +4 more
doaj   +1 more source

Factors associated with the circulation of vaccine-derived polioviruses in children under five in Kilwa, Haut-Katanga province, Democratic Republic of Congo, 2022–2023

open access: yesBMC Infectious Diseases
Introduction Since the World Health Organization declared the African region free of wild poliovirus in August 2020, vaccine-derived polioviruses (VDPV) have remained the only form of poliovirus still circulating on the continent, including in the ...
Jean Blaise Yobo Iyala   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy